Last edition
News about "GlobalData"
Singapore fast-tracks medtech innovation with first regulatory reliance pilot: GlobalData
The six-month pilot of the Medical Device Regulatory Reliance Programme, running from 1 September, 2025 to 28 February, 2026, aims to expedite market access for Class B, C and D medical devices by reducing duplicate regulatory reviews and leveraging each other's approvals.
GlobalData | 18/09/2025 | By Dineshwori
Four Drugs in Race for First Bispecific ADC Approval: GlobalData
With 21 global approvals, ADCs generated USD 13.6 billion in 2024. BsADCs represent further opportunities in this field, by leveraging bi-specific antibodies that simultaneously bind two distinct targets.
GlobalData | 02/09/2025 | By Dineshwori
Biopharma Firms See 5.7 Percent Market Cap Drop in Q2 2025: Globaldata
Twenty biopharmaceutical companies have reported a 5.7 percent quarter-on-quarter (QoQ) downturn in their combined market capitalisation from USD 3.9 trillion on 31 March, 2025 to USD 3.7 trillion on 30 June, 2025.
GlobalData | 01/09/2025 | By Dineshwori
Abbott's US Diagnostics Sales Decline in Q2 Due to Falling COVID-19 Test Demand: GlobalData
Abbott Laboratories has continued to demonstrate steady performance in the US medical device market amid market shifts, though its diagnostics segment experienced a modest decline, according to new insights from GlobalData, a leading data and analytics firm.
GlobalData | 12/08/2025 | By Dineshwori | 109
US Tariffs on EU Pharma Imports Threaten Drug Access and Innovation, GlobalData Warns
The US-EU trade deal has placed the pharmaceutical industry under significant fiscal strain, with consequences that extend beyond short-term financials, according to GlobalData, a leading data and analytics company.
GlobalData | 05/08/2025 | By Dineshwori | 132
US Tariffs Pose Serious Challenges for India's Key Export Sectors, Including Pharma: GlobalData
GlobalData has warned that the US tariffs, coupled with penalties linked to India’s dealings with Russian energy and military supplies, could pose serious challenges for key export sectors, including electronics, pharmaceuticals, automobiles, and textiles.
GlobalData | 05/08/2025 | By Dineshwori | 155
FDA Drug Approvals Fall in 2024, But Small Pharma Fuels Innovation Surge
The US Food and Drug Administration (FDA) approved 127 innovator and biosimilar drugs in 2024, marking a decline from the 149 approvals recorded in 2023, according to a report by leading data and analytics firm GlobalData.
GlobalData | 19/07/2025 | By Dineshwori | 149
Endometriosis Market to Triple by 2034, Driven by Novel Therapies and Rising Diagnoses: GlobalData
This robust growth is attributed to the expected launch of innovative therapies such as Kissei Pharmaceutical’s Yselty (linzagolix), a GnRH antagonist already available in Europe and soon launching in the US and Japan.
GlobalData | 04/07/2025 | By Darshana | 133
GlobalData: Indian pharma should grab opportunities to supply oral Covid-19 drugs to global market
The Indian pharma manufacturers may see more demand for oral Covid-19 drugs from various parts of the world, as a larger opportunity in the global supply pool is opening up, says GlobalData, a leading data and analytics company.
GlobalData | 21/11/2021 | By Darshana | 198
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy